ArticleEJHaem2022
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
Darcy B Pooler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleEJHaem2022
Darcy B Pooler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.